Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Topco ScientificLtd Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Topco ScientificLtd wird ein Gewinn- und Umsatzwachstum von 12.9% bzw. 12.6% pro Jahr prognostiziert, während der Gewinn pro Aktie um 12.2% pro Jahr wachsen soll.

Wichtige Informationen

12.9%

Wachstumsrate der Gewinne

12.2%

EPS-Wachstumsrate

Semiconductor Gewinnwachstum	18.8%
Wachstumsrate der Einnahmen	12.6%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	21 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

I Built A List Of Growing Companies And Topco ScientificLtd (TPE:5434) Made The Cut

Mar 29

We Think Topco ScientificLtd (TPE:5434) Can Stay On Top Of Its Debt

Mar 16

Topco ScientificLtd (TPE:5434) Has Gifted Shareholders With A Fantastic 177% Total Return On Their Investment

Mar 01

Topco Scientific Co.,Ltd.'s (TPE:5434) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Feb 15

Is Topco Scientific Co.,Ltd. (TPE:5434) The Right Choice For A Smart Dividend Investor?

Feb 01

Is Topco Scientific Co.,Ltd. (TPE:5434) Trading At A 29% Discount?

Jan 18

Is Topco ScientificLtd (TPE:5434) Likely To Turn Things Around?

Jan 05

We Think Topco ScientificLtd (TPE:5434) Can Stay On Top Of Its Debt

Dec 10

Shareholders Of Topco ScientificLtd (TPE:5434) Must Be Happy With Their 211% Total Return

Nov 27

Gewinn- und Umsatzwachstumsprognosen

TWSE:5434 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (TWD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2025	61,039	3,631	4,017	4,385	2
12/31/2024	55,772	3,380	3,302	3,670	2
3/31/2024	48,713	2,870	-1,865	3,105	N/A
12/31/2023	49,273	2,835	-197	1,620	N/A
9/30/2023	50,417	2,767	-666	940	N/A
6/30/2023	51,718	2,868	977	2,232	N/A
3/31/2023	52,888	3,098	1,325	2,554	N/A
12/31/2022	52,978	3,018	2,792	3,184	N/A
9/30/2022	51,367	3,087	2,211	2,567	N/A
6/30/2022	48,563	2,787	1,807	2,067	N/A
3/31/2022	45,719	2,500	2,069	2,424	N/A
12/31/2021	42,669	2,294	2,181	2,597	N/A
9/30/2021	39,841	2,209	2,417	2,859	N/A
6/30/2021	37,920	2,138	1,844	2,284	N/A
3/31/2021	36,911	2,067	1,757	2,103	N/A
12/31/2020	36,168	2,068	1,724	2,007	N/A
9/30/2020	36,045	1,923	1,827	2,101	N/A
6/30/2020	35,135	1,879	2,486	2,711	N/A
3/31/2020	33,391	1,792	1,564	1,776	N/A
12/31/2019	31,701	1,722	1,442	1,758	N/A
9/30/2019	30,300	1,717	900	1,264	N/A
6/30/2019	29,604	1,650	566	973	N/A
3/31/2019	29,521	1,526	706	1,105	N/A
12/31/2018	28,861	1,405	802	1,094	N/A
9/30/2018	27,785	1,210	396	647	N/A
6/30/2018	26,366	1,120	58	326	N/A
3/31/2018	24,649	1,009	469	862	N/A
12/31/2017	23,781	998	N/A	824	N/A
9/30/2017	22,911	1,108	N/A	1,225	N/A
6/30/2017	22,385	1,091	N/A	842	N/A
3/31/2017	22,697	1,171	N/A	1,736	N/A
12/31/2016	22,629	1,203	N/A	1,734	N/A
9/30/2016	22,090	1,134	N/A	1,536	N/A
6/30/2016	21,268	1,091	N/A	1,820	N/A
3/31/2016	19,656	1,027	N/A	1,057	N/A
12/31/2015	19,079	958	N/A	710	N/A
9/30/2015	18,741	933	N/A	441	N/A
6/30/2015	18,826	916	N/A	823	N/A
3/31/2015	19,026	899	N/A	689	N/A
12/31/2014	18,092	860	N/A	1,047	N/A
9/30/2014	17,197	818	N/A	1,591	N/A
6/30/2014	16,309	773	N/A	1,156	N/A
3/31/2014	15,592	783	N/A	589	N/A
12/31/2013	15,555	798	N/A	694	N/A
9/30/2013	15,798	805	N/A	414	N/A
6/30/2013	16,184	857	N/A	1,116	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 5434Das prognostizierte Gewinnwachstum (12.9% pro Jahr) liegt über der Sparquote (1%).

Ertrag vs. Markt: 5434Die Erträge des Unternehmens (12.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt TW (18% pro Jahr).

Hohe Wachstumserträge: 5434Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: 5434Die Einnahmen des Unternehmens (12.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt TW (10.7% pro Jahr).

Hohe Wachstumseinnahmen: 5434Die Einnahmen des Unternehmens (12.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von 5434 in 3 Jahren voraussichtlich hoch sein wird

Topco ScientificLtd Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates increase by 11%

Price target increased by 10% to NT$220

Price target increased by 7.5% to NT$210

Price target increased to NT$174

Topco Scientific Co.,Ltd. Announces Occupational Accident in Xiang Yueh Co., Ltd

Price target increased to NT$150

Recent updates

Topco Scientific Co.,Ltd. Announces Cash Dividend, Payable on July 19, 2024

Consensus EPS estimates increase by 11%

First quarter 2024 earnings: EPS exceeds analyst expectations

Topco Scientific Co.,Ltd. to Report Q1, 2024 Results on May 02, 2024

Topco Scientific Co.,Ltd.'s (TWSE:5434) Prospects Need A Boost To Lift Shares

Are Investors Undervaluing Topco Scientific Co.,Ltd. (TWSE:5434) By 20%?

Price target increased by 10% to NT$220

Topco Scientific Co.,Ltd., Annual General Meeting, May 30, 2024

Full year 2023 earnings: EPS misses analyst expectations

Topco Scientific Co.,Ltd. Approves Cash Dividends for the Year 2023

Topco Scientific Co.,Ltd. Announces Cash Dividend

New major risk - Earnings quality

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New minor risk - Shareholder dilution

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Topco Scientific Co.,Ltd. Announces Executive Changes

Upcoming dividend of NT$10.00 per share at 3.0% yield

Topco Scientific Co.,Ltd. Appoints Kuan-Hung as Director

Topco Scientific Co.,Ltd. Announces Cash Dividend, Payable on July 14, 2023

Price target increased by 7.5% to NT$210

Full year 2022 earnings: EPS misses analyst expectations

Topco Scientific Co.,Ltd. announced that it has received $6.913941 million in funding

Less than half of directors are independent

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of NT$8.80 per share

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Price target increased to NT$174

Less than half of directors are independent

Topco Scientific Co.,Ltd. Announces Occupational Accident in Xiang Yueh Co., Ltd

Price target increased to NT$150

Upcoming dividend of NT$8.00 per share

First quarter 2021 earnings released: EPS NT$2.50 (vs NT$2.51 in 1Q 2020)

A Look At The Intrinsic Value Of Topco Scientific Co.,Ltd. (TPE:5434)

Topco ScientificLtd's (TPE:5434) Returns Have Hit A Wall

Full year 2020 earnings released: EPS NT$11.38 (vs NT$9.48 in FY 2019)

I Built A List Of Growing Companies And Topco ScientificLtd (TPE:5434) Made The Cut

Topco Scientific Co.,Ltd. Announces Distribution for the Year Ended December 31, 2020

We Think Topco ScientificLtd (TPE:5434) Can Stay On Top Of Its Debt

Topco ScientificLtd (TPE:5434) Has Gifted Shareholders With A Fantastic 177% Total Return On Their Investment

Topco Scientific Co.,Ltd.'s (TPE:5434) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Is Topco Scientific Co.,Ltd. (TPE:5434) The Right Choice For A Smart Dividend Investor?

New 90-day high: NT$126

Is Topco Scientific Co.,Ltd. (TPE:5434) Trading At A 29% Discount?

Is Topco ScientificLtd (TPE:5434) Likely To Turn Things Around?

We Think Topco ScientificLtd (TPE:5434) Can Stay On Top Of Its Debt

Shareholders Of Topco ScientificLtd (TPE:5434) Must Be Happy With Their 211% Total Return

Earnings beat expectations, revenue disappoints

Third quarter 2020 earnings released: EPS NT$2.87

New 90-day high: NT$124

First half earnings released

Price target raised to NT$130

New 90-day high - NT$124

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken